Communicable Diseases clinical trials
The registry lists 626 studies for Communicable Diseases across more than 10 countries. 128 are recruiting or about to start. 299 of them are mainly about Communicable Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 23 narrower conditions too, such as HIV Infections: 12,556 studies, 1,223 open.
ClinicalTrials.gov finds 29,046 studies for Communicable Diseases. How that becomes 626 here
This page counts the studies the registry files under Communicable Diseases, and those it files under no condition that list Communicable Diseasesthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count
- 29,046Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −11,714Filed under a narrower condition, counted on its own pageHIV Infections 4,664 · Acquired Immunodeficiency Syndrome 1,886 · Hepatitis C 1,527 · Hepatitis B 847 · Hepatitis B, Chronic 684 · Hepatitis C, Chronic 572 · 17 more
- −125List Communicable Diseases as a condition, but the registry did not file them under itMost often written as “Skin Diseases, Infectious” (24), “Pneumococcal Infectious Disease” (12), and “Bone Diseases, Infectious” (8). The registry filed 33 of them under no condition at all, and the others under other conditions only, most often Skin Diseases, Infectious (27) and COVID-19 (12).
- −16,581Match it another way125 name it in the title, 37 in a keyword, and 16,419 by a synonym or other text the search reads.
- 626The count on this page
Get an email when these change. Save the Communicable Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
National Center for Research Resources (NCRR) (25) · National Institute of Allergy and Infectious Diseases (NIAID) (15) · Assistance Publique - Hôpitaux de Paris (10) · BLIS Technologies Limited (7) · Emory University (7) · Johns Hopkins University (7) · University of Alabama at Birmingham (4) · Karolinska Institutet (4)
What is being tested here
Drugs under test in Communicable Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Hepatitis B Virus Antisense Oligonucleotide AHB-137 | 2 | 0 | 2 |
| Azithromycin | 1 | 1 | 4 |
| BWC0977 | 1 | 0 | 3 |
| Tafenoquine | 1 | 0 | 2 |
| Favipiravir | 1 | 1 | 2 |
| Chlorhexidine | 1 | 1 | 2 |
| 2-Propanol | 1 | 1 | 2 |
| Bepirovirsen | 1 | 0 | 1 |
| Naproxen | 1 | 1 | 1 |
| Dexamethasone | 1 | 1 | 1 |
Drug classes tested here Beta-lactamase inhibitors 1 open · Reverse transcriptase inhibitors 3
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- May 2027Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia · Phase 3 · Assistance Publique - Hôpitaux de Paris
- Nov 2026Molecular Culture for the Diagnosis of Pediatric Sepsis · Jip Groen
- Dec 2026A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor · Brigham and Women's Hospital
- Dec 2026Autoflor -Lyophilized Capsulated Autological FMT to Restore Gut Microbiome After Treatment With Antibiotics · Otto Helve
- Dec 2026The Genital Microbiome of Male Partners of Women With Recurrent BV Undergoing Vaginal Microbiome Transplantation · Hadassah Medical Organization
- Dec 2026Skin Preparation for Elective Foot and Ankle Surgery · University of Missouri-Columbia
- Dec 2026Prescription Support System for Antimicrobial Use in Belgian Primary Care · KU Leuven
- Dec 2026Effects of Pulse Consumption, Gut Microbiome, and Appetite in Healthy Participants · University of Missouri-Columbia
- Dec 2026Gut Microbiome Analysis in Organ Transplant Recipient · Asan Medical Center
- Dec 2026Design of an Integrative Algorithm for Staging Tuberculosis · Fundació Institut Germans Trias i Pujol
Who these studies take
Of the 92 Communicable Diseases studies recruiting now, 49 (53%) set no upper age limit and 32 (35%) stop at 75 or younger. 36 (39%) take children under 18. 6 (7%) are for women only and 1 (1%) for men only; 40 (43%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 28 (30%) | 28 (30%) |
| 18 | 72 (78%) | 67 (73%) |
| 30 | 74 (80%) | 69 (75%) |
| 40 | 75 (82%) | 71 (77%) |
| 50 | 71 (77%) | 70 (76%) |
| 65 | 68 (74%) | 67 (73%) |
| 75 | 61 (66%) | 60 (65%) |
| 85 | 57 (62%) | 56 (61%) |
Across all 626 studies, recruiting or not: 41% stop at 75 or younger and 35% at 65; 37% take children; 9% are for women only and 1% for men only; 49% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Communicable Diseases studies take
Of 25 phase 1 interventional studies under Communicable Diseases, half reached primary completion within 13 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 13 mo5–18 · 25 studies | — | — |
| Phase 2 | 18 mo12–38 · 22 studies | — | — |
| Phase 3 | 40 mo21–54 · 16 studies | — | — |
| Phase 4 | 38 mo17–65 · 13 studies | — | — |
| Interventional, no phase | 21 mo6–36 · 144 studies | — | 21 mo6–36 · 128 studies |
| Observational | 37 mo17–94 · 142 studies | — | 37 mo18–77 · 128 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 50 of 626. Browse all 626 → or search them.
- Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging Infectious DiseasesRecruitingNCT012009531 country
- Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIVRecruitingNCT000012811 country
- Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe RegionsRecruitingNCT07654283Phase 26 countries
- A Study to Compare Blood Levels of Bepirovirsen and Safety Using Different Methods of Injecting in Healthy Adult ParticipantsNot yet recruitingNCT07905157Phase 1
- POS-ARI-ER Observational Study of Acute Respiratory InfectionsRecruitingNCT0581423710 countries
- High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) RecipientsRecruitingNCT05947071Phase 21 country
- Topical Sevoflurane for Treatment of Chronic Leg UlcersRecruitingNCT05303805Phase 41 country
- Biospecimen Analysis in Detecting Chemical Concentrations in Patients With Chronic or Infectious Diseases Receiving MeditationsRecruitingNCT041604291 country
- High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)RecruitingNCT07192458Phase 21 country
- CytOSorb TreatMent Of Critically Ill PatientS RegistryRecruitingNCT051463366 countries
- Naproxen Versus Placebo as Adjunct Treatment of CellulitisNot yet recruitingNCT07665476Phase 31 country
- Rickettsia Clearance StudyRecruitingNCT05972772Phase 2/31 country
- Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific RegionRecruitingNCT07370207Phase 27 countries
- Restoration of the Gut Microbiome After Cesarean SectionRecruitingNCT06264219Phase 11 country
- Comparative Autoantibody and Immunologic Cell Marker StudyEnrolling by invitationNCT024228751 country
- A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy VolunteersRecruitingNCT07029932Phase 11 country
- Cohort of the Specialist Network Infectious DiseasesRecruitingNCT068791841 country
- The Genital Microbiome of Male Partners of Women With Recurrent BV Undergoing Vaginal Microbiome TransplantationRecruitingNCT05963711Not applicable1 country
- Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National CohortRecruitingNCT067620021 country
- Metagenomic Sequencing Across the Infectious Disease Risk and Care ContinuumNot yet recruitingNCT07825714
- Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their ParentsRecruitingNCT053943631 country
- Understanding the Burn Wound Microbiome: Comparing Traditional Wound Cultures to Next Generation Sequencing TechnologyRecruitingNCT052753351 country
- A Dietitian-Driven Unified Nutritional Care Model (ADDUCE)RecruitingNCT07730996Not applicable1 country
- Early Corticosteroids in Severe Influenza PneumoniaNot yet recruitingNCT07786662Phase 31 country
- An International Observational Study of Adults With Acute InfectionRecruitingNCT0706940021 countries
- Protection Motivation Theory-Based Education for Infectious Disease Prevention in Primary CareNot yet recruitingNCT07790367Not applicable1 country
- Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin TreatmentRecruitingNCT06805994Phase 11 country
- A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)RecruitingNCT06422338Not applicable2 countries
- Compliant Analysis of Patient Samples and DataEnrolling by invitationNCT043645031 country
- Prescription Support System for Antimicrobial Use in Belgian Primary CareRecruitingNCT07347015Not applicable1 country
- Metabolic and Infectious Diseases in La Réunion (the REUNION Population-based Study)RecruitingNCT054008241 country
- Genetic Susceptibility to Severe InfectionsRecruitingNCT061020701 country
- Molecular Microbiology- Guided Antimicrobial Stewardship Versus Standard Stewardship in Hospitalized PatientsRecruitingNCT07684300Not applicable1 country
- Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor ScoreRecruitingNCT076815831 country
- Changes in Microbial Status From Dentate, Edentulous and After Dental Implant PlacementRecruitingNCT061495851 country
- Biological Collection on Emerging Infectious Diseases and Their TreatmentsNot yet recruitingNCT076745501 country
- Suivi Prospectif Des ostéomyélites de la Base du crâneNot yet recruitingNCT076658661 country
- Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB)RecruitingNCT068937571 country
- Research Project on the Interaction Between Immune Function and Infectious Diseases in Older Adults and the Development of Prevention and Control StrategiesNot yet recruitingNCT07644962
- Preparing for Maternal GBS Vaccine Trials in AfricaRecruitingNCT068339574 countries
- Topical Curcumin for HPV Related Cervical DiseaseNot yet recruitingNCT04266275Phase 21 country
- Improved Child Nutrition and Development Through Social TransfersNot yet recruitingNCT07569172Not applicable1 country
- A Phase I Study of PepGNP-ChikV in Healthy VolunteersNot yet recruitingNCT07394426Early Phase 1
- The Role of the Human Microbiome in Patients After Pancreatic Resection.Enrolling by invitationNCT063818821 country
- Skin Preparation for Elective Foot and Ankle SurgeryRecruitingNCT05401292Phase 41 country
- Oral Microbiome in Carotid AtherosclerosisRecruitingNCT072969651 country
- Pharmacogenomics for Better Treatment of Fungal Infections Clinical TrialRecruitingNCT06510699Phase 22 countries
- Oral Lactobacillus Reuteri for Skin Barrier Dysfunction in ObesityNot yet recruitingNCT07512050Not applicable
- Genetics of UveitisRecruitingNCT023572381 country
- Synbiotics in Patients at RIsk fOr Preterm BirthRecruitingNCT05966649Not applicable1 country